OncoLens is an oncology intelligence platform that delivers oncology intelligence to cancer care providers and life science companies. Nearly 88% of actionable oncology insight lives in unstructured data, and most tools only read the structured fields. OncoLens reads the whole record, enabling customers to harness this data to improve patient outcomes, HCP education and clinical efficiency. For life sciences, OncoLens supports commercial, clinical development, market access, RWE and HEOR, CRO and biobank teams through Real World Data, data driven timely signals for HCP education and patient identification for clinical trials. Through the OncoLens Research Network, partners reach cancer centers to identify eligible patients, support biomarker testing, and accelerate trial enrollment. Half of the top 20 pharma companies partner with OncoLens. For providers, OncoLens is the multidisciplinary cancer care platform for tumor boards, registry automation, accreditation reporting, oncology analytics and AI driven patient pre-screening. More than 225 U.S. cancer center locations and 45,000 multidisciplinary physicians have used the platform. OncoLens integrates with Epic, Oracle Cerner, MEDITECH, athenahealth, and OncoEMR, and with Guardant Health, Caris Life Sciences, Tempus, and Foundation Medicine. The platform is SOC 2 certified. OncoLens was founded in Atlanta in 2017. Contact us at info@oncolens.com for a demo.